Robyn Manley
Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii
Manley, Robyn; Fitch, Christian; Francis, Vanessa; Temperton, Isaac; Turner, Dann; Fletcher, Julie; Phil, Mitchelmore; Michell, Steve; Temperton, Ben
Authors
Christian Fitch
Vanessa Francis
Isaac Temperton
Dr Dann Turner Dann2.Turner@uwe.ac.uk
Senior Lecturer in Genomics
Julie Fletcher
Mitchelmore Phil
Steve Michell
Ben Temperton
Abstract
Introduction . Acinetobacter baumannii is a critical priority pathogen for novel antimicrobials (World Health Organization) because of the rise in nosocomial infections and its ability to evolve resistance to last resort antibiotics. A. baumannii is thus a priority target for phage therapeutics. Two strains of a novel, virulent bacteriophage (LemonAid and Tonic) able to infect carbapenem-resistant A. baumannii (strain NCTC 13420), were isolated from environmental water samples collected through a citizen science programme. Gap statement. Phage-host coevolution can lead to emergence of host resistance, with a concomitant reduction in the virulence of host bacteria; a potential benefit to phage therapy applications. Methodology. In vitro and in vivo assays, genomics and microscopy techniques were used to characterize the phages; determine mechanisms and impact of phage resistance on host virulence, and the efficacy of the phages against A. baumannii. Results. A. baumannii developed resistance to both viruses, LemonAid and Tonic. Resistance came at a cost to virulence, with the resistant variants causing significantly reduced mortality in a Galleria mellonella larval in vivo model. A replicated 8 bp insertion increased in frequency (~40 % higher frequency than in the wild-type) within phage-resistant A. baumannii mutants, putatively resulting in early truncation of a protein of unknown function. Evidence from comparative genomics and an adsorption assay suggests this protein acts as a novel phage receptor site in A. baumannii. We find no evidence linking resistance to changes in capsule structure, a known virulence factor. LemonAid efficiently suppressed growth of A. baumanni in vitro across a wide range of titres. However, in vivo, while survival of A. baumannii infected larvae significantly increased with both remedial and prophylactic treatment with LemonAid (107 p.f.u. ml–1), the effect was weak and not sufficient to save larvae from morbidity and mortality. Conclusion. While LemonAid and Tonic did not prove effective as a treatment in a Galleria larvae model, there is potential to harness their ability to attenuate virulence in drug-resistant A. baumannii.
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 10, 2024 |
Online Publication Date | May 14, 2024 |
Publication Date | May 14, 2024 |
Deposit Date | May 15, 2024 |
Publicly Available Date | May 15, 2024 |
Journal | Journal of Medical Microbiology |
Print ISSN | 0022-2615 |
Electronic ISSN | 1473-5644 |
Publisher | Microbiology Society |
Peer Reviewed | Peer Reviewed |
Volume | 73 |
Issue | 5 |
Article Number | 001829 |
DOI | https://doi.org/10.1099/jmm.0.001829 |
Public URL | https://uwe-repository.worktribe.com/output/11989292 |
Publisher URL | https://www.microbiologyresearch.org/ |
Files
Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii
(2.1 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
Comparative analysis of multiple inducible phages from Mannheimia haemolytica
(2015)
Journal Article
A proposed new bacteriophage subfamily: “Jerseyvirinae”
(2015)
Journal Article
661W photoreceptor cell line as a cell model for studying retinal ciliopathies
(2019)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search